|
Volumn 40, Issue 2, 1999, Pages 244-259
|
Financing pharmaceuticals in transition economies
|
Author keywords
Agency relationships in health care policy and research; Cost containment; Decision making, organizational; Disease costs; Health and industrial policy; Pharmaceutical economics; Pharmacy administration; Policy making; Reimbursement mechanisms
|
Indexed keywords
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
HEALTH CARE COST;
HEALTH CARE FINANCING;
HEALTH CARE MANAGEMENT;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH PROMOTION;
HUMAN;
PHARMACEUTICS;
PHARMACIST;
PHARMACOECONOMICS;
PHYSICIAN;
PRACTICE GUIDELINE;
PROFIT;
PUBLIC HEALTH;
REVIEW;
COST CONTROL;
COSTS AND COST ANALYSIS;
DRUG COSTS;
ECONOMICS, PHARMACEUTICAL;
HEALTH TRANSITION;
HUMANS;
LEGISLATION, DRUG;
|
EID: 0032794747
PISSN: 03539504
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (20)
|
References (27)
|